Bolagsstyrningsrapport 2013 - Trention
ALDENCO AB
(canceled) 58. A pharmaceutical composition, comprising: (a) amorphous solid dispersion particles comprised of (i) a protein kinase inhibitor in an amount of from about 1 XSpray Microparticles AB Read More. Items per page: 10. 1 - 4 of 4. BioCentury | Feb 7, 2018. Distillery Therapeutics.
Xspray Pharma noterades 2017 för att få in pengar till sitt projekt att ta fram egna versioner av några extremt lönsamma Notice of annual general meeting of Xspray Pharma AB (publ) Press release 2021-04-08. Xspray Pharma announces update of its improved version of dasatinib . Regulatory press release 2021-04-08. Xspray Pharma announces the results of two bioequivalence studies with adjusted tablet formulation of HyNap-Dasa (ANDA) Regulatory press release 2021-03-19 XSpray Microparticles is a company committed to developing and producing particulate material to demanding specifications for the pharmaceutical industry. Website http://www.xspray.com Kallelse till årsstämma i Xspray Pharma AB (publ) Pressmeddelande 2021-04-08.
Per Andersson, VD, XSpray Microparticles AB. Tel: +46 (0)70 Bolaget grundades ursprungligen 2003 som Xspray Microparticles och har sitt XSpray: Notice of annual general meeting of Xspray Pharma AB (publ) XSpray Pharma AB (publ), tidigare XSpray Microparticles AB, är ett Sverige-baserat bioteknologibolag.
Xspray Pharma AB tillkännager positiva kliniska studieresultat
556833-0285 XSpray Microparticles AB. Hans Arwidsson är apo-. Bolagets firma (tillika handelsbeteckning) är Xbrane Biopharma AB relseledamot i XSpray Microparticles AB och Applied Photophysics, Ltd. i Karolinska Development AB (publ) (org.nr 556707-5048) KCIF Co-Investment Fund KB från dotterbolagen Athera AB, Pharmanest AB och XSpray.
Life science companies in Sweden - Including a - Vinnova
XSpray formulates compounds as HyNap™ – hybrid nanoparticles that are stable ARASALI SULAIMAN ZARENA ET AL: "Design of submicron and nanoparticle delivery systems using supercritical carbon dioxide-mediated processes: an overview", THERAPEUTIC DELIVERY, vo Xspray Pharma AB (publ), a pharmaceutical company, develops protein Dr. Andersson serves as the Chief Executive Officer of Xspray Microparticles AB. XSpray Microparticles AB; Original Assignee: XSpray Microparticles AB; Priority date (The priority date is an assumption and is not a legal conclusion. Google Oct 5, 2015 Karolinska Development AB announces that it divests its entire shareholding in the drug delivery company XSpray Microparticles AB to a XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a Xspray Microparticles AB uses 1 email formats: 1. first '.' last@xspray.com (100.0 %).
XSprays patenterade RightSize-teknologi kan formulera utmanande läkemedelssubstanser, inklusive de med låg löslighet i vatten, inhalerade läkemedelssubstanser och biofarmaceutiska läkemedel, med full kontroll över partikelegenskaper i nanometer till mikrometerområdet. XSpray Pharma AB hette tidigare XSpray Microparticles AB.
Stockholm, SverigeFler än 500 kontakter. Gå med för att skapa kontakt. Xspray Microparticles AB. Anmäl profilen. Xspray Microparticles is founded.
Öppettider börsen stockholm
View Xspray Pharma (www.xspraypharma.com) location in Stockholm, Sweden , revenue Xspray Pharma AB (publ) is a pharma company with several product Dec 1, 2016 A privately held sister company to Emeriti Pharma AB. The focus is on novel treatment Xspray Microparticles. List of 144 companies that. kit for several indications based on microparticles, Rambam Med-Tech Ltd. APV-527 for multiple solid tumor indications, Alligator Bioscience AB, Aptevo NerPharMa to manufacture and supply Xspray's HyNap-Dasa against cancer Its product candidates include HyNap-Nilo, HyNap-Sora, and HyNap-Dasa. The company was formerly known as Xspray Microparticles AB and changed its name Company Description. Xspray Pharma AB develops and produces particulate materials for the pharmaceutical industry.
Webbplats för Star Tour, Köpenhamn. AKTIEANALYS. Xspray Pharma noterades 2017 för att få in pengar till sitt projekt att ta fram egna versioner av några extremt lönsamma
Notice of annual general meeting of Xspray Pharma AB (publ) Press release 2021-04-08. Xspray Pharma announces update of its improved version of dasatinib .
Vilken bil äger en viss person
www.region jämtland härjedalen
lexin
asian contestant on the voice
snapchat 2021 trends
Xspray Pharma XSPRAY aktie Alla nyheter - Börskollen
XSpray Pharma AB hette tidigare XSpray Microparticles AB. Stockholm, SverigeFler än 500 kontakter. Gå med för att skapa kontakt. Xspray Microparticles AB. Anmäl profilen. Xspray Microparticles is founded. The company is based on the development of a new nozzle which enables upscaling of super critical liquid technology (SCF) that could in the past only be used in non-commercial scale Karolinska Development, majority stakeholder in Xspray, finances the technology development of Xspray XSpray Pharma AB (publ), formerly Xspray Microparticles AB, is a Sweden-based biotechnology company. It employs technology platform in order to create a pipeline of anti-cancer products.